opioid-induced constipation

When is bad press not so bad? When it's building a market, AstraZeneca says of its Super Bowl experiment
When is bad press not so bad? When it's building a market, AstraZeneca says of its Super Bowl experiment
Fierce Pharma
AstraZeneca
opioid-induced constipation
opioids
Flag link:
Valeant And Progenics Announce The U.S. Commercial Launch Of FDA-Approved Relistor® Tablets
Valeant And Progenics Announce The U.S. Commercial Launch Of FDA-Approved Relistor® Tablets
Yahoo
Valeant Pharmaceuticals
Progenics
Relistor
opioid-induced constipation
Flag link:
How Will AstraZeneca (AZN) Stock React to FDA's Movantik Approval?
How Will AstraZeneca (AZN) Stock React to FDA's Movantik Approval?
TheStreet.com
AstraZeneca
Movantik
FDA
opioid-induced constipation
Nektar
Flag link:
FDA approves AstraZeneca, Nektar constipation drug
FDA approves AstraZeneca, Nektar constipation drug
Yahoo/Reuters
FDA
AstraZeneca
Nektar
Movantik
opioid-induced constipation
Flag link:
AstraZeneca's Naloxegol Data Published
AstraZeneca's Naloxegol Data Published
Yahoo/Zacks
AstraZeneca
Naloxegol
opioid-induced constipation
Flag link:
FDA panel advises against large opioid-constipation drug safety trials
FDA panel advises against large opioid-constipation drug safety trials
Yahoo/Reuters
FDA
advisory panels
opioid-induced constipation
Flag link:
U.S. FDA advisors set to review opioid constipation drugs
U.S. FDA advisors set to review opioid constipation drugs
Yahoo/Reuters
FDA
opioid-induced constipation
Salix
Relistor
Cubist Pharmaceuticals
Entereg
AstraZeneca
Nektar
Naloxegol
Flag link:
Nektar Rises on FDA Notification
Nektar Rises on FDA Notification
Yahoo/Zacks.com
FDA
Nektar
AstraZeneca
Naloxegol
opioid-induced constipation
Flag link:
Sucampo Receives $10 Million Milestone Payment from Takeda on First Sale of AMITIZA® (lubiprostone) for OIC in the US
Sucampo Receives $10 Million Milestone Payment from Takeda on First Sale of AMITIZA® (lubiprostone) for OIC in the US
Yahoo
Sucampo
Takeda
Amitiza
opioid-induced constipation
Flag link:
AstraZeneca says Phase III studies of Naloxegol met primary, secondary endpoints
AstraZeneca says Phase III studies of Naloxegol met primary, secondary endpoints
The Fly on the Wall
AstraZeneca
Naloxegol
opioid-induced constipation
Flag link:
Sucampo Wins Approval for Expanded Use of Amitiza in U.S.
Sucampo Wins Approval for Expanded Use of Amitiza in U.S.
Bloomberg
Sucampo
Amitiza
opioid-induced constipation
Flag link:
Strength In Sucampo Heading Into FDA Decision And Analyst Activity
Strength In Sucampo Heading Into FDA Decision And Analyst Activity
Seeking Alpha
Sucampo
FDA
Rescula
Amitiza
opioid-induced constipation
Flag link: